Trading a GERN straddle lets you take a pure volatility position on Geron Corp without committing to a direction. Geron Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate GERN straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on GERN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Geron Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the GERN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the GERN straddle is the cleanest expression of that view. Our scanner prices every GERN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a GERN straddle into a catalyst or short a GERN straddle to harvest decay, the options straddle setups that matter are all in one place.
